Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial

Soon Kyu Lee, Hyun Yang, Jung Hyun Kwon, Dong Jae Shim, Doyoung Kim, Soon Woo Nam, Sun Hong Yoo, Si Hyun Bae, Ahlim Lee, Young Joon Lee, Changho Jeon, Jeong Won Jang, Pil Soo Sung, Ho Jong Chun, Su Ho Kim, Joon-Il Choi, Jung Suk Oh, Yun-Jung Yang

Open source

DOI: 10.1186/s13063-023-07266-4
Published: 2023-03-28
Container: Trials
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13063-023-07266-4,
  title = {Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial},
  author = {Soon Kyu Lee and Hyun Yang and Jung Hyun Kwon and Dong Jae Shim and Doyoung Kim and Soon Woo Nam and Sun Hong Yoo and Si Hyun Bae and Ahlim Lee and Young Joon Lee and Changho Jeon and Jeong Won Jang and Pil Soo Sung and Ho Jong Chun and Su Ho Kim and Joon-Il Choi and Jung Suk Oh and Yun-Jung Yang},
  year = {2023},
  journal = {Trials},
  doi = {10.1186/s13063-023-07266-4},
  url = {https://doi.org/10.1186/s13063-023-07266-4}
}

RIS

TY  - JOUR
TI  - Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial
AU  - Soon Kyu Lee
AU  - Hyun Yang
AU  - Jung Hyun Kwon
AU  - Dong Jae Shim
AU  - Doyoung Kim
AU  - Soon Woo Nam
AU  - Sun Hong Yoo
AU  - Si Hyun Bae
AU  - Ahlim Lee
AU  - Young Joon Lee
AU  - Changho Jeon
AU  - Jeong Won Jang
AU  - Pil Soo Sung
AU  - Ho Jong Chun
AU  - Su Ho Kim
AU  - Joon-Il Choi
AU  - Jung Suk Oh
AU  - Yun-Jung Yang
PY  - 2023
JO  - Trials
DO  - 10.1186/s13063-023-07266-4
UR  - https://doi.org/10.1186/s13063-023-07266-4
ER  -

APA

Lee, S. K., Yang, H., Kwon, J. H., Shim, D. J., Kim, D., Nam, S. W., Yoo, S. H., Bae, S. H., Lee, A., Lee, Y. J., Jeon, C., Jang, J. W., Sung, P. S., Chun, H. J., Kim, S. H., Choi, J., Oh, J. S., & Yang, Y. (2023). Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial. Trials. https://doi.org/10.1186/s13063-023-07266-4

Source records

crossref · retrieved 2026-09-25T21:25:12.534Z